PMID- 35433869 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20220503 IS - 2297-055X (Print) IS - 2297-055X (Electronic) IS - 2297-055X (Linking) VI - 9 DP - 2022 TI - Establishment of Reference Interval and Aging Model of Homocysteine Using Real-World Data. PG - 846685 LID - 10.3389/fcvm.2022.846685 [doi] LID - 846685 AB - OBJECTIVE: The level of Homocysteine (Hcy) in males is generally higher than that of females, but the same reference interval (RI) is often used in clinical practice. This study aims to establish a sex-specific RI of Hcy using five data mining algorithms and compare these results. Furthermore, age-related continuous RI was established in order to show the relationship between Hcy concentration distribution and age. METHODS: A total of 20,801 individuals were included in the study and Tukey method was used to identify outliers in subgroups by sex and age. Multiple linear regression and standard deviation ratio (SDR) was used to determine whether the RI for Hcy needs to be divided by sex and age. Five algorithms including Hoffmann, Bhattacharya, expectation maximization (EM), kosmic and refineR were utilized to establish the RI of Hcy. Generalized Additive Models for Location Scale and Shape (GAMLSS) algorithm was used to determine the aging model of Hcy and calculate the age-related continuous RI. RESULTS: RI of Hcy needed to be partitioned by sex (SDR = 0.735 > 0.375). RIs established by Hoffmann, Bhattacharya, EM (for females) and kosmic are all within the 95% CI of reference limits established by refine R. The Sex-specific aging model of Hcy showed that the upper limits of the RI of Hcy declined with age beginning at age of 18 and began to rise approximately after age of 40 for females and increased with age for males. CONCLUSION: The RI of Hcy needs to be partitioned by sex. The RIs established by the five data mining algorithms showed good consistency. The dynamic sex and age-specific model of Hcy showed the pattern of Hcy concentration with age and provide more personalized tools for clinical decisions. CI - Copyright (c) 2022 Ma, Li, Wang, Hou, Xia, Yin, Cheng and Qiu. FAU - Ma, Chaochao AU - Ma C AD - Department of Laboratory Medicine, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China. FAU - Li, Lei AU - Li L AD - Department of Laboratory Medicine, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China. FAU - Wang, Xinlu AU - Wang X AD - Department of Medical Laboratory Technology, Public Health College, Nanchang University, Nanchang, China. FAU - Hou, Li'an AU - Hou L AD - Department of Laboratory Medicine, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China. FAU - Xia, Liangyu AU - Xia L AD - Department of Laboratory Medicine, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China. FAU - Yin, Yicong AU - Yin Y AD - Department of Laboratory Medicine, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China. FAU - Cheng, Xinqi AU - Cheng X AD - Department of Laboratory Medicine, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China. FAU - Qiu, Ling AU - Qiu L AD - Department of Laboratory Medicine, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China. AD - State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China. LA - eng PT - Journal Article DEP - 20220330 PL - Switzerland TA - Front Cardiovasc Med JT - Frontiers in cardiovascular medicine JID - 101653388 PMC - PMC9005842 OTO - NOTNLM OT - GAMLSS algorithm OT - aging model OT - big data mining OT - homocysteine OT - reference interval COIS- The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. EDAT- 2022/04/19 06:00 MHDA- 2022/04/19 06:01 PMCR- 2022/01/01 CRDT- 2022/04/18 06:39 PHST- 2021/12/31 00:00 [received] PHST- 2022/03/02 00:00 [accepted] PHST- 2022/04/18 06:39 [entrez] PHST- 2022/04/19 06:00 [pubmed] PHST- 2022/04/19 06:01 [medline] PHST- 2022/01/01 00:00 [pmc-release] AID - 10.3389/fcvm.2022.846685 [doi] PST - epublish SO - Front Cardiovasc Med. 2022 Mar 30;9:846685. doi: 10.3389/fcvm.2022.846685. eCollection 2022.